The risk of thromboembolic events with early intravenous 2‐ and 4‐g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double‐blind, placebo‐controlled, single‐center trial-Reference-Cited by-同舟云学术

The risk of thromboembolic events with early intravenous 2‐ and 4‐g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double‐blind, placebo‐controlled, single‐center trial

Published:2022-06-29 Issue:S1 Volume:62 Page:
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Spinella Philip C.¹^ORCID,Bochicchio Kelly²,Thomas Kimberly A.¹^ORCID,Staudt Amanda³,Shea Susan M.¹^ORCID,Pusateri Anthony E.⁴,Schuerer Douglas²,Levy Jerrold H.⁵^ORCID,Cap Andrew P.⁶,Bochicchio Grant²

Affiliation:

1. Trauma and Transfusion Medicine Research Center, Department of Surgery University of Pittsburgh Pittsburgh PA USA

2. Department of Surgery, Division of Acute Care Surgery Washington University School of Medicine St. Louis Missouri USA

3. Clinical Research Support Branch The Geneva Foundation Fort Sam Houston Texas USA

4. Naval Medical Research Unit –San Antonio Fort Sam Houston Texas USA

5. Departments of Anesthesiology, Critical Care, and Surgery (Cardiothoracic) Duke University School of Medicine, Durham, North Carolina USA Durham North Carolina‐NC 27710 USA

6. United States Army Institute of Surgical Research Fort Sam Houston Texas USA

Funder

U.S. Department of Defense

US Army Institute of Surgical Research

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16962

Reference41 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010